APA (7th ed.) Citation

Dominguez, A. N., Bhurwal, A., Mutneja, H., Eichinger, S. E., Pinnam, B., Rivera, D. G., & Pan, C. A Comparison of Intravenous Infliximab Versus Subcutaneous Infliximab on Remission Rates, Safety, Costs, Patient Preferences in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Elsevier.

Chicago Style (17th ed.) Citation

Dominguez, Alejandro Nieto, Abhishek Bhurwal, Hemant Mutneja, Sarah E. Eichinger, Bhanu Pinnam, Daniel Guifarro Rivera, and Chun-Wei Pan. A Comparison of Intravenous Infliximab Versus Subcutaneous Infliximab on Remission Rates, Safety, Costs, Patient Preferences in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Elsevier.

MLA (9th ed.) Citation

Dominguez, Alejandro Nieto, et al. A Comparison of Intravenous Infliximab Versus Subcutaneous Infliximab on Remission Rates, Safety, Costs, Patient Preferences in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Elsevier.